Vivo Capital VIII, LLC Insider Trading $CRNX Crinetics Pharmaceuticals, Inc.
Get free email notifications about insider trading for Vivo Capital VIII, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vivo Capital VIII, LLC. Vivo Capital VIII, LLC is 10% Owner in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in BioPharmX Corp ($TPND) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Nabriva Therapeutics plc ($NBRV) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Vivo Capital VIII, LLC in Crinetics Pharmaceuticals, Inc.
Trading Symbol: CRNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vivo Capital VIII, LLC: 10% Owner
Holdings: 2,263,447 shares
Latest Transaction: Apr 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Vivo Capital VIII, LLC in Crinetics Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, BOLT, CRNX, IMPL, NBRV, TERN, TMBR, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.40 | 10,265 | 158,081 | 298,625 | 308.9 K to 298.6 K (-3.32 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.40 | 74,333 | 1,144,728 | 2,162,587 | 2.2 M to 2.2 M (-3.32 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.20 | 3,663 | 55,678 | 308,890 | 312.6 K to 308.9 K (-1.17 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.20 | 26,527 | 403,210 | 2,236,920 | 2.3 M to 2.2 M (-1.17 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.50 | 26,185 | 405,868 | 312,553 | 338.7 K to 312.6 K (-7.73 %) |
Apr 17 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 15.50 | 189,625 | 2,939,188 | 2,263,447 | 2.5 M to 2.3 M (-7.73 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 14.20 | 742 | 10,536 | 338,738 | 339.5 K to 338.7 K (-0.22 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 14.20 | 5,373 | 76,297 | 2,453,072 | 2.5 M to 2.5 M (-0.22 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 13.80 | 36,400 | 502,320 | 339,480 | 375.9 K to 339.5 K (-9.68 %) |
Apr 07 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 13.80 | 263,600 | 3,637,680 | 2,458,445 | 2.7 M to 2.5 M (-9.68 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 133 | 2,594 | 168,165 | 168.3 K to 168.2 K (-0.08 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 48 | 936 | 375,880 | 375.9 K to 375.9 K (-0.01 %) |
Mar 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 19.50 | 347 | 6,767 | 2,722,045 | 2.7 M to 2.7 M (-0.01 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 5,904 | 126,346 | 168,298 | 174.2 K to 168.3 K (-3.39 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 200 | 4,280 | 375,928 | 376.1 K to 375.9 K (-0.05 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.40 | 1,451 | 31,051 | 2,722,392 | 2.7 M to 2.7 M (-0.05 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 4,614 | 101,508 | 174,202 | 178.8 K to 174.2 K (-2.58 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 157 | 3,454 | 376,128 | 376.3 K to 376.1 K (-0.04 %) |
Feb 11 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.00 | 1,134 | 24,948 | 2,723,843 | 2.7 M to 2.7 M (-0.04 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 10,519 | 239,833 | 178,816 | 189.3 K to 178.8 K (-5.56 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 357 | 8,140 | 376,285 | 376.6 K to 376.3 K (-0.09 %) |
Feb 06 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.80 | 2,584 | 58,915 | 2,724,977 | 2.7 M to 2.7 M (-0.09 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 4,220 | 91,574 | 189,335 | 193.6 K to 189.3 K (-2.18 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 143 | 3,103 | 376,642 | 376.8 K to 376.6 K (-0.04 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 21.70 | 1,037 | 22,503 | 2,727,561 | 2.7 M to 2.7 M (-0.04 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 5,940 | 131,274 | 193,555 | 199.5 K to 193.6 K (-2.98 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 201 | 4,442 | 376,785 | 377 K to 376.8 K (-0.05 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.10 | 1,459 | 32,244 | 2,728,598 | 2.7 M to 2.7 M (-0.05 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 10,878 | 241,492 | 199,495 | 210.4 K to 199.5 K (-5.17 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 369 | 8,192 | 376,986 | 377.4 K to 377 K (-0.10 %) |
Jan 31 2020 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.20 | 2,673 | 59,341 | 2,730,057 | 2.7 M to 2.7 M (-0.10 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 83,984 | 1,868,644 | 210,373 | 294.4 K to 210.4 K (-28.53 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 40,407 | 899,056 | 377,355 | 417.8 K to 377.4 K (-9.67 %) |
Mar 25 2019 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Sell | S | 22.25 | 292,609 | 6,510,550 | 2,732,730 | 3 M to 2.7 M (-9.67 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 187,648 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,358,903 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,163,311 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 8,424,416 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 20.73 | 153,180 | 3,175,421 | 294,357 | 141.2 K to 294.4 K (+108.50 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 141,177 | 2,400,009 | 141,177 | 0 to 141.2 K |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 7,137 | 121,329 | 417,762 | 410.6 K to 417.8 K (+1.74 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 51,686 | 878,662 | 3,025,339 | 3 M to 3 M (+1.74 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 57,035 | 0 | 410,625 | 353.6 K to 410.6 K (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 413,040 | 0 | 2,973,653 | 2.6 M to 3 M (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 353,590 | 0 | 353,590 | 0 to 353.6 K |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 2,560,613 | 0 | 2,560,613 | 0 to 2.6 M |
Page: 1